Heat shock factor 1 deficiency via its downstream target gene αB-crystallin (Hspb5) impairs p53 degradation

Journal of Cellular Biochemistry

Volumn 107, Issue 3, 2009, Pages 504-515

  Jin, Xiongjie ^a   Moskophidis, Demetrius ^a   Hu, Yanzhong ^a   Phillips, Andrew ^b,c   Mivechi, Nahid F ^a,b  

^a Center for Molecular Chaperones/Radiobiology and Cancer Virology   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

B crystallin; HSF1; p53 degradation

Indexed keywords

ALPHA B CRYSTALLIN; CRYSTALLIN; CYCLIN D1; DOXORUBICIN; HEAT SHOCK TRANSCRIPTION FACTOR 1; PROTEIN P53; UBIQUITIN LIGASE FBX4; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL STRAIN U20S; DNA DAMAGE; EMBRYO; FIBROBLAST; IMMUNOPRECIPITATION; MOLECULAR MECHANICS; MOUSE; MOUSE EMBRYO; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WILD TYPE;

ALPHA-CRYSTALLIN B CHAIN; ANIMALS; DNA-BINDING PROTEINS; F-BOX PROTEINS; MICE; MICE, KNOCKOUT; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 66749139638     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22151     Document Type: Article

References (40)

1. Arndt V, Rogon C, Hohfeld J. 2007. To be, or not to be-Molecular chaperones in protein degradation. Cell Mol Life Sci 64(19-20): 2525-2541. (Pubitemid 350035611)
2. Ashcroft M, Kubbutat MH, Vousden KH. 1999. Regulation of p53 function and stability by phosphorylation. Mol Cell Biol 19:1751-1758. (Pubitemid 29098233)
3. Barbash O, Lin DI, Diehl JA. 2007. SCF Fbx4/alphaB-crystallin cyclin D1 ubiquitin ligase: A license to destroy. Cell Dev 2:2. (Pubitemid 46730812)
4. Barral JM, Broadley SA, Schaffar G, Hartl FU. 2004. Roles of molecular chaperones in protein misfolding diseases. Semin Cell Dev Biol 15:17-29. (Pubitemid 38177364)
5. Brady JP, Garland DL, Green DE, Tamm ER, Giblin FJ, Wawrousek EF. 2001. B-Crystallin in lens development and muscle integrity: A gene knockout approach. Invest Ophthalmol Vis Sci 42:2924-2934. (Pubitemid 33035292)
6. Bruins W, Zwart E, Attardi LD, Iwakuma T, Hoogervorstm EM, Beems RB, Miranda B, van Oostrom CT, van den Berg J, van den Aardweg GJ, Lozano G, van Steeg H, Jacks T, de Vries A. 2004. Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389. Mol Cell Biol 24:8884-8894. (Pubitemid 39313894)
7. Cadwell C, Zambetti GP. 2001. The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth. Gene 277:15-30. (Pubitemid 32972107)
8. Ciocca DR, Calderwood SK. 2005. Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86-103. (Pubitemid 40942470)
9. Crook T, Marston NJ, Sara EA, Vousden KH. 1994. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79:817-827. (Pubitemid 24371972)
10. den Engelsman J, Keijsers V, de Jong WW, Boelens WC. 2003. The small heatshock protein alpha B-crystallin promotes FBX4-dependent ubiquitination. J Biol Chem 278:4699-4704. (Pubitemid 36800969)
11. Esser C, Scheffner M, Hohfeld J. 2005. The chaperone associated ubiquitin ligase CHIP is able to target p53 for proteosomal degradation. J Biol Chem 280:27443-27448. (Pubitemid 41040787)
12. Germano S, Barberis D, Santoro MM, Penengo L, Citri A, Yarden Y, Gaudino G. 2006. Geldanamycins trigger a novel Ron degradative pathway, hampering oncogenic signaling. J Biol Chem 281:21710-21719. (Pubitemid 44181874)
13. Giaccia AJ, Kastan MB. 1998. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev 12:2973-2983. (Pubitemid 28469299)
14. Hartl F. 1996. Molecular chaperones and cellular protein folding. Nature 381:571-579. (Pubitemid 26177472)
15. Haslbeck M. 2002. sHsps and their role in the chaperone network. Cell Mol Life Sci 59:1649-1657. (Pubitemid 35346968)
16. Hohfeld J, Cyr DM, Patterson C. 2001. From the cradle to the grave: Molecular chaperones that may choose between folding and degradation. EMBO Rep 2:885-890. (Pubitemid 33040574)
17. Homma S, Jin X, Wang G, Tu N, Min J, Yanasak N, Mivechi NF. 2007. Demyelination, astrogliosis, and accumulation of ubiquitinated proteins, hallmarks of CNS disease in hsf1-deficient mice. J Neurosci 27:7974-7986. (Pubitemid 47173325)
18. Hu Y, Mivechi NF. 2006. Association and regulation of heat shock transcription factor 4b with both extracellular signal-regulated kinase mitogen-activated protein kinase and dual-specificity tyrosine phosphatase DUSP26. Mol Cell Biol 26:3282-3294.
19. Huang L, Min J-N, Masters S, Mivechi NF, Moskophidis D. 2007. Insights into function and regulation of small heat shock protein 25 (HSPB1) in a mouse model with targeted gene disruption. Genesis 45:487-501. (Pubitemid 47584207)
20. Jolly C, Morimoto RI. 2000. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 92:1564-1572.
21. Lakin ND, Jackson SP. 1999. Regulation of p53 in response to DNA damage. Oncogene 18:7644-7655. (Pubitemid 30052691)
22. Lavin MF, Gueven N. 2006. The complexity of p53 stabilization and activation. Cell Death Differ 13:941-950. (Pubitemid 43753485)
23. Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, Klein-Szanto AJ, Rustgi A, Fuchs SY, Diehl JA. 2006. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alpha B crystallin) complex. Mol Cell 24:355-366. (Pubitemid 44647901)
24. LoweSW, Ruley HE. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 7:535-545. (Pubitemid 23125255)
25. Min JN, Huang L, Zimonjic DB, Moskophidis D, Mivechi NF. 2007. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene 26:5086-5097. (Pubitemid 47206948)
26. Morimoto RI. 1998. Regulation of the heat shock transcriptional response: Cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 12:3788-3796. (Pubitemid 29024840)
27. Muchowski PJ. 2002. Protein misfolding, amyloid formation, and neurodegeneration: A critical role for molecular chaperone? Neuron 35:9-12.
28. Nakayama KI, Nakayama K. 2005. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin Cell Dev Biol 16:323-333. (Pubitemid 40504221)
29. Nakayama KI, Nakayama K. 2006. Ubiquitin ligases: Cell cycle control and cancer. Nature Rev Cancer 6:369-381.
30. Oren M. 1999. The p53 saga: The good, the bad and the dead. Harvey Lect 97:57-82.
31. Parcellier A, Schmitt E, Gurbuxani S, Seigneurin-Berny D, Pance A, Chantome A, Plenchette S, Khochbin S, Solary E, Garrido C. 2003. HSP27 is a ubiquitin-binding protein involved in I-kappaB alpha proteasomal degradation. Mol Cell Biol 23:5790-5802. (Pubitemid 36951341)
32. Samuelson AV, Lowe SW. 1997. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc Natl Acad Sci 94:12094-12099. (Pubitemid 27467848)
33. Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA, Van Pelt CS, Lozano G. 2008. The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. Genes Dev 22:1337-1344.
34. Whitesell L, Lindquist SL. 2005. HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761-772. (Pubitemid 41400776)
35. Whitesell L, Sutphin PD, Pulcini EJ, Martinez JD, Cook PH. 1998. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol 18:1517-1524. (Pubitemid 28100917)
36. Wu C. 1995. Heat shock transcription factors: Structure and regulation. Ann Rev Cell Dev Biol 11:441-469. (Pubitemid 26019611)
37. Xu W, Marcu M, Yuan X, Mimnaugh E, Patterson C, Neckers L. 2002. Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu. Proc Natl Acad Sci USA 99:12847-12852.
38. Zambetti GP, Levine AJ. 1993. A comparison of the biological activities of wild-type and mutant p53. FASEB J 7:855-865. (Pubitemid 23225541)
39. Zhang Y, Huang L, Zhang J, Moskophidis D, Mivechi NF. 2002. Targeted disruption of hsf1 leads to lack of thermotolerance and defines tissue-specific regulation for stress-inducible Hsps. J Cell Biochem 86:376-393. (Pubitemid 34743394)
40. Zylicz M, King FW, Wawrzynow A. 2001. Hsp70 interactions with the p53 tumor suppressor protein. EMBO J 20:4634-4638. (Pubitemid 32848616)